Growth and spread of human malignant T lymphoblasts in immunosuppressed nude mice: a model for meningeal leukemia.

Previous work has shown that nude (nu/nu) mice additionally immunosuppressed by splenectomy, sublethal irradiation, and treatment with antiasialo GM1 antiserum (SIA-nu/nu mice) have no detectable natural killer activity and allow the growth of human malignant lymphoblasts. We show here that all SIA-nu/nu mice engrafted intravenously with 5 x 10(6) malignant lymphoblasts originally derived from a child with a T-cell acute lymphoblastic leukemia (PF382) and from a boy with a T-cell lymphoma (ST-4) develop lethal meningeal leukemia and die within 35 days. Histologic examination of moribund SIA-nu/nu mice showed that vertebral and skull bone marrow was always replaced by proliferating human T lymphoblasts. From the spinal canal, lymphoblasts spread to the meninges, causing hind leg paralysis. Leaving the skull, they permeated the meninges and then invaded the nervous parenchyma. This efficient and reproducible experimental model may be suitable for experimental studies on the pathogenesis of meningeal leukemia.

[1]  P. Mischel,et al.  The Central Nervous System: Structure and Function , 2004, Journal of Neurology.

[2]  R. Foà,et al.  Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin , 1990, British journal of haematology.

[3]  R. Foà,et al.  Establishment of an EBV‐positive lymphoblastoid cell line that grows as a lymphoma in nude mice and expresses membrane CD2 molecules , 1990, International journal of cancer.

[4]  A. Modesti,et al.  A new childhood T-cell lymphoma established in nude mice and in vitro. , 1988, Cancer Research.

[5]  G. Forni,et al.  Serial Transplantation of a Human Acute T Lymphoblastic Leukemia into Nude Mice , 1986, Tumori.

[6]  Craig W. Reynolds,et al.  Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. , 1985, Journal of immunology.

[7]  G. Forni,et al.  Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth. , 1985, Journal of immunology.

[8]  C. Kase,et al.  Pathogenesis of an experimental meningeal leukemia model. , 1982, Clinical immunology and immunopathology.

[9]  C. Kase,et al.  Pathology of an experimental extradural spinal T cell tumor. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[10]  J. Varakis,et al.  New experimental model of meningeal leukemia. , 1980, Cancer research.

[11]  C. Riccardi,et al.  Rapid in vivo assay of mouse natural killer cell activity. , 1979, Journal of the National Cancer Institute.

[12]  B. Giovanella,et al.  The Nude Mouse in Experimental and Clinical Research , 1978 .

[13]  M. Chirigos,et al.  An animal model for meningeal leukemia , 1974, International journal of cancer.

[14]  L. Thomas.  Pathology of leukemia in the brain and meninges: postmortem studies of patients with acute leukemia and of mice given inoculations of L1210 leukemia. , 1965, Cancer research.

[15]  J. Phair,et al.  THE CENTRAL NERVOUS SYSTEM IN LEUKEMIA. , 1964, Annals of internal medicine.

[16]  J. V. Cooke.  ACUTE LEUKEMIA IN CHILDREN , 1933 .

[17]  C. Riccardi,et al.  Growth and dissemination of human malignant lymphoblasts in immunosuppressed nu/nu mice. , 1991, Natural immunity and cell growth regulation.

[18]  C. Pochedly.  Meningeal leukemia: current concepts in biology and treatment. Introduction. , 1989, The American journal of pediatric hematology/oncology.

[19]  W. Bleyer,et al.  Biology and pathogenesis of CNS leukemia. , 1989, The American journal of pediatric hematology/oncology.

[20]  E. E. Brongers.  [Acute leukemia in children]. , 1957, Nederlands tijdschrift voor geneeskunde.